Comorbidity of substance abuse with other psychiatric disorders (Q33285122)

25 July 2017

1 reference

title

Comorbidity of substance abuse with other psychiatric disorders (English)

1 reference

25 July 2017

1 reference

1 reference

Tomas Palomo

1

1 reference

25 July 2017

Trevor Archer

series ordinal

2

1 reference

25 July 2017

Richard M Kostrzewa

series ordinal

3

1 reference

25 July 2017

Richard J Beninger

series ordinal

4

1 reference

25 July 2017

1 July 2007

1 reference

25 July 2017

Neurotoxicity Research

1 reference

25 July 2017

12

1 reference

25 July 2017

1

1 reference

25 July 2017

17-27

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03033898

25 July 2017

0 references

cites work

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1007%2FBF03033898

Model psychoses and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033898

Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033898

Catecholamines in the brain as mediators of amphetamine psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033898

Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants

21 January 2018

1 reference

12 December 2020

N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells

1 reference

12 December 2020

Schizophrenia as a progressive disorder: relations to EEG, CT, neuropathological and other evidence

1 reference

12 December 2020

Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine

1 reference

12 December 2020

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

1 reference

12 December 2020

Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward?

1 reference

12 December 2020

Dramatic decreases in brain reward function during nicotine withdrawal.

1 reference

12 December 2020

Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders

1 reference

12 December 2020

Desmethylimipramine attenuates cocaine withdrawal in rats

1 reference

12 December 2020

Effects of chronic amphetamine treatment on the glutamate concentration in cerebrospinal fluid and brain: Implications for a theory of schizophrenia

1 reference

12 December 2020

The role of dopamine in locomotor activity and learning

1 reference

12 December 2020

Animal models and treatments for addiction and depression co-morbidity

1 reference

12 December 2020

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

1 reference

12 December 2020

Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers

1 reference

12 December 2020

Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories

1 reference

12 December 2020

A psychomotor stimulant theory of addiction.

1 reference

12 December 2020

Individual vulnerability to substance abuse and affective disorders: role of early environmental influences

1 reference

12 December 2020

Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation.

1 reference

12 December 2020

The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization

1 reference

12 December 2020

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

1 reference

12 December 2020

Gene-environment interplay in schizopsychotic disorders

1 reference

12 December 2020

Importance of clinical diagnoses for comorbidity studies in substance use disorders

1 reference

12 December 2020

Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task

1 reference

12 December 2020

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 reference

12 December 2020

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study

1 reference

12 December 2020

Substance misuse in patients with schizophrenia: epidemiology and management

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Ketamine: an update on the first twenty-five years of clinical experience

1 reference

12 December 2020

DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling

1 reference

12 December 2020

Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers

1 reference

12 December 2020

A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use.

1 reference

12 December 2020

Dissociation Of working memory from decision making within the human prefrontal cortex

1 reference

12 December 2020

Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?

1 reference

12 December 2020

Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder

1 reference

12 December 2020

Noradrenaline and 5-hydroxytryptamine metabolism in six areas of rat brain during post-amphethamine depression

1 reference

12 December 2020

Dysfunction of ventral striatal reward prediction in schizophrenia

1 reference

12 December 2020

Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions

1 reference

12 December 2020

Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens.

1 reference

12 December 2020

Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain

1 reference

12 December 2020

Traumatic life events and PTSD among women with substance use disorders and schizophrenia.

1 reference

12 December 2020

Failure to respond autonomically to anticipated future outcomes following damage to prefrontal cortex

1 reference

12 December 2020

Emotion, decision making and the orbitofrontal cortex

1 reference

12 December 2020

Finding schizophrenia genes

1 reference

12 December 2020

Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats

1 reference

12 December 2020

Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats

1 reference

12 December 2020

The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia

1 reference

12 December 2020

Insensitivity to future consequences following damage to human prefrontal cortex

1 reference

12 December 2020

Pharmacotherapy for schizophrenia and co-occurring substance use disorders

1 reference

12 December 2020

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

1 reference

12 December 2020

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

1 reference

12 December 2020

Preexposure during or following adolescence differently affects nicotine-rewarding properties in adult rats

1 reference

12 December 2020

Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain

1 reference

12 December 2020

Long term neurodevelopmental and behavioral effects of perinatal life events in rats

1 reference

12 December 2020

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study

1 reference

12 December 2020

Smoking, smoking cessation, and major depression

1 reference

12 December 2020

Effects of ketamine in normal and schizophrenic volunteers

1 reference

12 December 2020

Size and burden of depressive disorders in Europe

1 reference

12 December 2020

Dopamine and incentive learning: a framework for considering antipsychotic medication effects

1 reference

12 December 2020

The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?

1 reference

12 December 2020

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

1 reference

12 December 2020

Synchronous activity in the hippocampus and nucleus accumbens in vivo.

1 reference

12 December 2020

Deciding advantageously before knowing the advantageous strategy

1 reference

12 December 2020

Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms

1 reference

12 December 2020

Euphorigenic drugs: effects on the reward pathways of the brain

1 reference

12 December 2020

Concomitant clozapine reduces smoking in patients treated with risperidone

1 reference

12 December 2020

Drug addiction: the neurobiology of disrupted self-control.

1 reference

12 December 2020

Acute and long-term regulation of brain alpha 2-adrenoceptors after manipulation of noradrenergic transmission in the rat

1 reference

12 December 2020

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

12 December 2020

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

1 reference

12 December 2020

Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia.

1 reference

12 December 2020

The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone

1 reference

12 December 2020

Chronic cocaine self-administration upregulates the norepinephrine transporter and alters functional activity in the bed nucleus of the stria terminalis of the rhesus monkey

1 reference

12 December 2020

Delayed mesolimbic system alteration in a developmental animal model of schizophrenia.

1 reference

12 December 2020

Double activity imaging reveals distinct cellular targets of haloperidol, clozapine and dopamine D(3) receptor selective RGH-1756.

1 reference

12 December 2020

Pathophysiologically based treatment interventions in schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033898

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference